1. Home
  2. SOTK vs ACET Comparison

SOTK vs ACET Comparison

Compare SOTK & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

HOLD

Current Price

$4.95

Market Cap

73.7M

Sector

Technology

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$9.61

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOTK
ACET
Founded
1975
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.7M
83.3M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
SOTK
ACET
Price
$4.95
$9.61
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
N/A
$48.33
AVG Volume (30 Days)
28.8K
80.5K
Earning Date
05-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
37.50
N/A
EPS
0.05
N/A
Revenue
$20,909,315.00
N/A
Revenue This Year
$4.02
N/A
Revenue Next Year
$10.95
N/A
P/E Ratio
$99.79
N/A
Revenue Growth
1.97
N/A
52 Week Low
$3.40
$0.46
52 Week High
$6.24
$9.84

Technical Indicators

Market Signals
Indicator
SOTK
ACET
Relative Strength Index (RSI) 44.59 57.58
Support Level $4.83 $7.45
Resistance Level $5.72 $9.59
Average True Range (ATR) 0.29 0.53
MACD -0.03 0.02
Stochastic Oscillator 15.63 73.95

Price Performance

Historical Comparison
SOTK
ACET

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: